David L Kolin, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometrial Neoplasms | 11 | 2023 | 1353 | 2.640 |
Why?
|
Carcinoma, Endometrioid | 5 | 2023 | 271 | 1.670 |
Why?
|
Uterine Neoplasms | 5 | 2022 | 1513 | 1.610 |
Why?
|
Fallopian Tube Neoplasms | 4 | 2024 | 324 | 1.520 |
Why?
|
Vulvar Neoplasms | 3 | 2022 | 272 | 1.480 |
Why?
|
Carcinoma | 6 | 2024 | 2375 | 1.140 |
Why?
|
Endometrial Stromal Tumors | 2 | 2023 | 44 | 1.090 |
Why?
|
Sarcoma, Endometrial Stromal | 2 | 2023 | 91 | 1.070 |
Why?
|
Endodermal Sinus Tumor | 2 | 2022 | 47 | 1.010 |
Why?
|
DNA Helicases | 4 | 2023 | 859 | 0.990 |
Why?
|
Fallopian Tubes | 4 | 2023 | 182 | 0.980 |
Why?
|
Oncogene Fusion | 2 | 2021 | 99 | 0.940 |
Why?
|
Kallikreins | 2 | 2015 | 258 | 0.910 |
Why?
|
Sarcoma | 3 | 2022 | 1897 | 0.790 |
Why?
|
WT1 Proteins | 1 | 2021 | 178 | 0.740 |
Why?
|
Pelvic Neoplasms | 1 | 2022 | 254 | 0.730 |
Why?
|
Rhabdoid Tumor | 2 | 2022 | 212 | 0.720 |
Why?
|
Vaginal Neoplasms | 1 | 2020 | 106 | 0.720 |
Why?
|
RNA-Binding Protein EWS | 1 | 2021 | 216 | 0.710 |
Why?
|
Adenomatoid Tumor | 1 | 2019 | 13 | 0.690 |
Why?
|
Sarcoma, Synovial | 1 | 2020 | 167 | 0.680 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 1 | 2020 | 105 | 0.640 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2020 | 198 | 0.630 |
Why?
|
Ovarian Neoplasms | 7 | 2024 | 4838 | 0.590 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2018 | 75 | 0.590 |
Why?
|
Nuclear Proteins | 5 | 2023 | 5853 | 0.580 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2018 | 221 | 0.550 |
Why?
|
Neurocutaneous Syndromes | 1 | 2016 | 51 | 0.550 |
Why?
|
Gene Amplification | 1 | 2020 | 1063 | 0.550 |
Why?
|
Genital Neoplasms, Female | 1 | 2021 | 523 | 0.530 |
Why?
|
Melanosis | 1 | 2016 | 78 | 0.530 |
Why?
|
Stomach Neoplasms | 2 | 2015 | 1333 | 0.520 |
Why?
|
Tissue Kallikreins | 1 | 2014 | 15 | 0.510 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1179 | 0.480 |
Why?
|
Cerebrospinal Fluid | 1 | 2016 | 534 | 0.460 |
Why?
|
Soft Tissue Neoplasms | 2 | 2022 | 1363 | 0.450 |
Why?
|
Transcription Factors | 7 | 2023 | 12208 | 0.450 |
Why?
|
GTP Phosphohydrolases | 1 | 2016 | 509 | 0.450 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2022 | 2020 | 0.440 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 594 | 0.410 |
Why?
|
Adenocarcinoma | 3 | 2021 | 6364 | 0.400 |
Why?
|
Receptor, erbB-2 | 2 | 2022 | 2416 | 0.400 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1692 | 0.400 |
Why?
|
Diagnosis, Differential | 4 | 2021 | 12959 | 0.390 |
Why?
|
Carcinoma, Small Cell | 2 | 2023 | 420 | 0.370 |
Why?
|
Serine Endopeptidases | 1 | 2015 | 1072 | 0.360 |
Why?
|
Tuberous Sclerosis | 1 | 2018 | 1029 | 0.350 |
Why?
|
Endometriosis | 1 | 2018 | 839 | 0.350 |
Why?
|
Spectrum Analysis | 3 | 2008 | 454 | 0.340 |
Why?
|
Rectal Neoplasms | 1 | 2018 | 1206 | 0.330 |
Why?
|
Green Fluorescent Proteins | 5 | 2007 | 2088 | 0.320 |
Why?
|
Immunohistochemistry | 6 | 2022 | 11366 | 0.320 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3597 | 0.310 |
Why?
|
Cystadenocarcinoma, Serous | 2 | 2024 | 450 | 0.310 |
Why?
|
Biophysics | 2 | 2006 | 383 | 0.310 |
Why?
|
Fluorescent Dyes | 4 | 2008 | 1917 | 0.300 |
Why?
|
Meningeal Neoplasms | 1 | 2016 | 1241 | 0.300 |
Why?
|
Integrin alpha5 | 1 | 2006 | 21 | 0.290 |
Why?
|
Actinin | 1 | 2007 | 160 | 0.280 |
Why?
|
Carcinoma in Situ | 2 | 2024 | 806 | 0.270 |
Why?
|
Spectrophotometry | 1 | 2005 | 313 | 0.260 |
Why?
|
Female | 32 | 2024 | 380194 | 0.260 |
Why?
|
beta Catenin | 2 | 2020 | 1059 | 0.250 |
Why?
|
Precancerous Conditions | 2 | 2021 | 975 | 0.230 |
Why?
|
Quantum Dots | 3 | 2011 | 172 | 0.230 |
Why?
|
CHO Cells | 6 | 2008 | 1406 | 0.220 |
Why?
|
RNA, Satellite | 1 | 2022 | 17 | 0.220 |
Why?
|
Cricetinae | 7 | 2008 | 2472 | 0.220 |
Why?
|
Myoepithelioma | 1 | 2022 | 43 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2022 | 9239 | 0.200 |
Why?
|
Metaplasia | 2 | 2020 | 313 | 0.200 |
Why?
|
Wolffian Ducts | 1 | 2021 | 23 | 0.200 |
Why?
|
Receptor, trkA | 1 | 2022 | 164 | 0.200 |
Why?
|
Vulvar Diseases | 1 | 2021 | 61 | 0.190 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2023 | 241 | 0.190 |
Why?
|
Adult | 16 | 2023 | 214055 | 0.190 |
Why?
|
Mutation | 4 | 2023 | 29786 | 0.190 |
Why?
|
Young Adult | 8 | 2023 | 56430 | 0.190 |
Why?
|
Middle Aged | 14 | 2023 | 213383 | 0.180 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2022 | 462 | 0.180 |
Why?
|
Nuclear Receptor Coactivator 1 | 1 | 2020 | 42 | 0.180 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2020 | 53 | 0.180 |
Why?
|
Microscopy, Fluorescence | 5 | 2008 | 2699 | 0.180 |
Why?
|
Humans | 35 | 2024 | 744343 | 0.180 |
Why?
|
Histone Acetyltransferases | 1 | 2022 | 336 | 0.180 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2020 | 37 | 0.180 |
Why?
|
Uterine Cervical Diseases | 1 | 2020 | 77 | 0.180 |
Why?
|
Cricetulus | 5 | 2008 | 816 | 0.170 |
Why?
|
Vaginal Diseases | 1 | 2020 | 102 | 0.170 |
Why?
|
Membrane Proteins | 1 | 2016 | 7880 | 0.170 |
Why?
|
Hypercalcemia | 1 | 2022 | 409 | 0.170 |
Why?
|
Diffusion | 5 | 2008 | 833 | 0.170 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 890 | 0.160 |
Why?
|
Choristoma | 1 | 2020 | 213 | 0.160 |
Why?
|
Epithelial Cells | 2 | 2020 | 3690 | 0.160 |
Why?
|
Melanoma | 1 | 2016 | 5510 | 0.160 |
Why?
|
Computer Simulation | 5 | 2008 | 6196 | 0.150 |
Why?
|
BRCA2 Protein | 2 | 2024 | 794 | 0.150 |
Why?
|
Prognosis | 4 | 2023 | 29063 | 0.150 |
Why?
|
Deoxycytidine | 1 | 2021 | 826 | 0.150 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2022 | 388 | 0.150 |
Why?
|
Chromosome Deletion | 1 | 2022 | 1401 | 0.150 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 501 | 0.150 |
Why?
|
Leiomyoma | 1 | 2022 | 730 | 0.140 |
Why?
|
Photobleaching | 2 | 2006 | 31 | 0.140 |
Why?
|
Gene Dosage | 1 | 2020 | 1252 | 0.130 |
Why?
|
DNA Copy Number Variations | 2 | 2023 | 1941 | 0.130 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2018 | 210 | 0.130 |
Why?
|
Aged, 80 and over | 6 | 2023 | 57776 | 0.130 |
Why?
|
Estrogen Receptor alpha | 1 | 2020 | 577 | 0.130 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 2012 | 0.130 |
Why?
|
RNA | 2 | 2022 | 2749 | 0.130 |
Why?
|
DNA Replication | 1 | 2021 | 1399 | 0.120 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2649 | 0.120 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1581 | 0.120 |
Why?
|
Aged | 9 | 2023 | 163280 | 0.120 |
Why?
|
Transfection | 3 | 2007 | 5892 | 0.120 |
Why?
|
Gene Deletion | 1 | 2022 | 2751 | 0.120 |
Why?
|
Observer Variation | 2 | 2021 | 2593 | 0.120 |
Why?
|
Uterus | 1 | 2018 | 711 | 0.120 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 553 | 0.110 |
Why?
|
Mesothelioma | 1 | 2019 | 818 | 0.110 |
Why?
|
Cytodiagnosis | 1 | 2016 | 435 | 0.110 |
Why?
|
Retrospective Studies | 4 | 2023 | 77449 | 0.110 |
Why?
|
Adenoma | 1 | 2023 | 2174 | 0.110 |
Why?
|
Prostate | 1 | 2020 | 1774 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2007 | 8949 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 4 | 2007 | 3772 | 0.100 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1788 | 0.090 |
Why?
|
Fluorescence | 2 | 2011 | 751 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2020 | 19905 | 0.080 |
Why?
|
Sensitivity and Specificity | 4 | 2020 | 14722 | 0.080 |
Why?
|
Paxillin | 1 | 2007 | 86 | 0.080 |
Why?
|
Lung Neoplasms | 3 | 2022 | 13102 | 0.080 |
Why?
|
Genomics | 1 | 2023 | 5720 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3703 | 0.070 |
Why?
|
Carbon-Nitrogen Ligases | 1 | 2006 | 28 | 0.070 |
Why?
|
Cell Membrane | 2 | 2006 | 3748 | 0.070 |
Why?
|
Adolescent | 4 | 2023 | 85781 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5535 | 0.060 |
Why?
|
Disease Progression | 1 | 2022 | 13284 | 0.060 |
Why?
|
Normal Distribution | 1 | 2005 | 280 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15076 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11524 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 6773 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5686 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12788 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6538 | 0.060 |
Why?
|
Microspheres | 1 | 2006 | 777 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2024 | 2948 | 0.060 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2006 | 437 | 0.060 |
Why?
|
Microscopy, Confocal | 2 | 2008 | 1970 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2020 | 11483 | 0.050 |
Why?
|
Spectrometry, Fluorescence | 1 | 2005 | 689 | 0.050 |
Why?
|
Protein Interaction Mapping | 1 | 2006 | 627 | 0.050 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2011 | 2540 | 0.050 |
Why?
|
Glypicans | 1 | 2022 | 34 | 0.050 |
Why?
|
Proteins | 2 | 2008 | 6103 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2023 | 8863 | 0.050 |
Why?
|
Integrins | 1 | 2006 | 846 | 0.050 |
Why?
|
Time Factors | 5 | 2021 | 40075 | 0.050 |
Why?
|
alpha-Fetoproteins | 1 | 2022 | 224 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2024 | 644 | 0.050 |
Why?
|
Photons | 1 | 2005 | 588 | 0.050 |
Why?
|
Northern Ireland | 1 | 2021 | 37 | 0.050 |
Why?
|
Embryo, Mammalian | 1 | 2007 | 1701 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 97 | 0.050 |
Why?
|
Risk Assessment | 1 | 2022 | 23338 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12354 | 0.050 |
Why?
|
Protein Transport | 1 | 2006 | 1988 | 0.050 |
Why?
|
Nanoparticles | 1 | 2011 | 1905 | 0.050 |
Why?
|
Isoxazoles | 1 | 2021 | 216 | 0.050 |
Why?
|
Fibroblasts | 2 | 2007 | 4161 | 0.040 |
Why?
|
Neprilysin | 1 | 2022 | 439 | 0.040 |
Why?
|
Light | 1 | 2005 | 1374 | 0.040 |
Why?
|
Escherichia coli Proteins | 1 | 2006 | 1050 | 0.040 |
Why?
|
Actins | 1 | 2006 | 2121 | 0.040 |
Why?
|
Animals | 10 | 2023 | 168757 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2022 | 63114 | 0.040 |
Why?
|
North America | 1 | 2021 | 1249 | 0.040 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2022 | 713 | 0.040 |
Why?
|
BRCA1 Protein | 1 | 2024 | 1149 | 0.040 |
Why?
|
Transsexualism | 1 | 2020 | 178 | 0.040 |
Why?
|
Artifacts | 1 | 2005 | 1904 | 0.040 |
Why?
|
Algorithms | 3 | 2006 | 13881 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2006 | 3327 | 0.030 |
Why?
|
Oncogenes | 1 | 2021 | 1265 | 0.030 |
Why?
|
Pyrazines | 1 | 2021 | 1230 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3282 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 20822 | 0.030 |
Why?
|
Male | 4 | 2020 | 350118 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2006 | 3023 | 0.030 |
Why?
|
Hormone Replacement Therapy | 1 | 2020 | 745 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2007 | 19229 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2187 | 0.030 |
Why?
|
Androgens | 1 | 2020 | 1281 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.030 |
Why?
|
Mice | 4 | 2023 | 81183 | 0.030 |
Why?
|
Models, Biological | 2 | 2006 | 9583 | 0.030 |
Why?
|
Models, Statistical | 1 | 2005 | 5102 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3586 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3638 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7301 | 0.020 |
Why?
|
Testosterone | 1 | 2020 | 2420 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4286 | 0.020 |
Why?
|
Chromogenic Compounds | 1 | 2007 | 30 | 0.020 |
Why?
|
Streptavidin | 1 | 2007 | 81 | 0.020 |
Why?
|
Glycosylphosphatidylinositols | 1 | 2007 | 94 | 0.020 |
Why?
|
Stochastic Processes | 1 | 2008 | 344 | 0.020 |
Why?
|
Fluorescence Recovery After Photobleaching | 1 | 2006 | 56 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11031 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2022 | 8428 | 0.020 |
Why?
|
5'-Nucleotidase | 1 | 2007 | 160 | 0.020 |
Why?
|
Models, Chemical | 1 | 2008 | 626 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 16689 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7729 | 0.020 |
Why?
|
Histidine | 1 | 2006 | 313 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8089 | 0.020 |
Why?
|
Biotin | 1 | 2006 | 254 | 0.020 |
Why?
|
3T3 Cells | 1 | 2006 | 1101 | 0.020 |
Why?
|
Phenotype | 1 | 2022 | 16365 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2006 | 853 | 0.010 |
Why?
|
Cell Line | 2 | 2007 | 15997 | 0.010 |
Why?
|
Cytoplasm | 1 | 2006 | 1539 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2006 | 1185 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2005 | 2327 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2006 | 1364 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2011 | 5524 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2006 | 3144 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2011 | 9734 | 0.010 |
Why?
|
Protein Binding | 1 | 2008 | 9386 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 72290 | 0.010 |
Why?
|
Child | 1 | 2020 | 77709 | 0.010 |
Why?
|
Kidney | 1 | 2006 | 7186 | 0.010 |
Why?
|